Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: 2cureX AB

Market Cap 7.43M 790K 683K 629K 589K 1.1M 75.13M 1.12M 2.9M 36.57M 2.97M 2.9M 127M P/E Ratio 2022
-4.81x
P/E Ratio 2023 -1.09x
Enterprise Value -5.97M -636K -549K -506K -474K -888K -60.43M -901K -2.33M -29.41M -2.39M -2.34M -102M EV / Sales 2022
29.3x
EV / Sales 2023 7.46x
Free-Float
34.89%
Yield 2022 *
-
Yield 2023 -
1 day-2.94%
1 week-7.72%
Current month-11.19%
1 month-15.38%
3 months+25.48%
6 months+120.59%
Current year+221.01%
1 week 1.65
Extreme 1.648
1.82
1 month 1.65
Extreme 1.648
2.16
Current year 0.52
Extreme 0.52
3.27
1 year 0.51
Extreme 0.514
4.88
3 years 0.2
Extreme 0.203
5.52
5 years 0.2
Extreme 0.203
19.4
10 years 0.2
Extreme 0.203
31.5
Manager TitleAgeSince
Chief Operating Officer 67 2005-12-31
Chief Executive Officer 73 -
Chief Executive Officer 50 2023-12-28
Director TitleAgeSince
Chairman 73 2024-12-15
Director/Board Member 67 2005-12-31
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.94%-7.72%-62.84%-67.39% 5.6M
-0.19%-2.87%+79.01%+75.36% 3.78B
-6.03%+4.14%+70.54%+100.46% 2.82B
+4.05%-2.03%-31.58%-39.75% 1.94B
+3.03%-3.55%+82.14%-53.85% 1.82B
-2.92%+3.24%+23.56%+174.76% 1.19B
-0.36%-6.03%-13.29%+15.43% 853M
-0.72%-22.50%+92.46% - 782M
-4.41%-0.80%+133.80%-65.98% 735M
+0.66%-4.95%-28.20%-15.87% 540M
Average -0.98%-1.81%+34.56%+13.69% 1.45B
Weighted average by Cap. -0.80%-0.54%+52.37%+40.62%

Financials

2022 2023
Net sales 3.37M 358K 310K 285K 267K 501K 34.07M 508K 1.31M 16.59M 1.35M 1.32M 57.43M 2.95M 314K 271K 250K 234K 438K 29.81M 445K 1.15M 14.51M 1.18M 1.15M 50.23M
Net income -29.77M -3.17M -2.74M -2.52M -2.36M -4.42M -301M -4.49M -11.61M -147M -11.89M -11.64M -507M -32.52M -3.46M -2.99M -2.75M -2.58M -4.83M -329M -4.91M -12.68M -160M -12.99M -12.71M -554M
Net Debt -44.89M -4.78M -4.13M -3.8M -3.56M -6.67M -454M -6.77M -17.5M -221M -17.93M -17.55M -765M -13.4M -1.43M -1.23M -1.14M -1.06M -1.99M -136M -2.02M -5.23M -65.98M -5.35M -5.24M -228M
Logo 2cureX AB
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
Employees
14
Date Price Change Volume
26-06-12 1.650 kr -2.94% 42,055
26-06-11 1.700 kr -3.41% 5,561
26-06-10 1.760 kr +0.23% 20,624
26-06-09 1.756 kr -0.23% 6,802
26-06-08 1.760 kr -1.57% 32,472
  1. Stock Market
  2. Stocks
  3. 2CUREX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!